Skip to main content
Clinical Trials/NCT04577131
NCT04577131
Terminated
Not Applicable

Improving Adherence to Home Blood Pressure Monitoring With Pharmacist Support

Virginia Commonwealth University1 site in 1 country1 target enrollmentNovember 5, 2020
ConditionsHypertension

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
Virginia Commonwealth University
Enrollment
1
Locations
1
Primary Endpoint
Change in adherence to home blood pressure monitoring
Status
Terminated
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this research study is to evaluate the impact of monitoring blood pressure from home everyday with pharmacist support.

Detailed Description

High blood pressure is very common and increases risk of heart, kidney, brain, and eye disease. It is important to diagnose and treat high blood pressure to reduce risk of these complications. Getting blood pressure checked only when someone sees a doctor is not the best way to diagnose high blood pressure or to make sure blood pressure is well managed. Checking blood pressure at home gives a better idea of whether someone's blood pressure is normal or too high. As part of their usual blood pressure monitoring, participants will be given an Omron 3 series or 5 series blood pressure monitor which has been cleared by the US Food and Drug Administration and validated to meet accuracy and performance requirements. For one month, participants will monitor their blood pressure once a day and then return the device to the clinic at the end of the study. Participants will text their blood pressure result to the American Heart Association's Check, Change, Control (CCC) secure online tracker. As part of the research study, participants will also be randomized to either receive or not receive weekly check-in phone calls from a pharmacist to review their blood pressures and the number of times they tested in that week. Approximately 50 individuals will participate in this study. Participation in this study will last 1 month.

Registry
clinicaltrials.gov
Start Date
November 5, 2020
End Date
November 5, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years of age and older
  • Uncontrolled hypertension (BP \> 130/80 mm Hg)

Exclusion Criteria

  • non-English speaking patients
  • patients without a mobile phone or texting capability

Outcomes

Primary Outcomes

Change in adherence to home blood pressure monitoring

Time Frame: 1 month

Proportion of days blood pressure is measured based on data from the blood pressuring monitor

Change in proportion of participants with a blood pressure <130/80 mm Hg.

Time Frame: 1 month

Proportion of participants with a blood pressure \<130/80 mm Hg.

Study Sites (1)

Loading locations...

Similar Trials